U.S. vs. European Health Care Systems: Cost and Outcome Gaps
This paper investigates the significant disparities between the United States and European health care systems, focusing on cost, accessibility, and health outcomes. Despite spending approximately $12,300 per capita — the highest among OECD nations — the U.S. records lower life expectancies and worse infant mortality rates than its European counterparts. The paper identifies key contributing factors, including the privatized structure of U.S. health care versus government-funded European models, pharmaceutical lobbying, immigration pressures, and the burden of uninsured populations. It also notes shared challenges such as aging populations and rising public demand, concluding that meaningful reform requires confronting entrenched private-sector interests.
- Introduction: Frames the U.S.-Europe health care cost paradox
- Overview of Health Care Systems in the U.S. and Europe: Compares spending, outcomes, and life expectancy data
- Factors Accounting for Differences in Health Care Costs: Analyzes privatization, pharma lobbying, and immigration
- Shared Challenges and Systemic Pressures: Aging populations and rising demand affect both systems
- Conclusion: Summarizes findings and calls for lobbying reform
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Uses concrete, up-to-date statistics (e.g., $12,300 U.S. per capita spending, OECD rankings) to ground comparative claims in measurable evidence.
- Draws on a range of source types — academic journals, policy foundations, and government data — lending credibility to the multi-factor analysis.
- Maintains a clear, consistent thesis throughout: the privatized U.S. funding model is the primary driver of cost and outcome disparities, reinforced by secondary factors like lobbying and uninsured populations.
Key academic technique demonstrated
The paper demonstrates effective comparative analysis by systematically contrasting two distinct health care systems across multiple dimensions — funding structure, pharmaceutical pricing, immigration policy, and demographic trends — rather than relying on a single explanatory variable. This layered approach allows the author to build a nuanced argument while still returning to a central claim.
Structure breakdown
The paper opens with a provocative epigraph that frames the central problem, followed by an introductory paragraph that states the purpose and roadmap. The first body section establishes the factual baseline through spending and outcome data. The second body section analyzes causal factors in detail. A transitional section addresses shared U.S.-European challenges before the conclusion synthesizes findings and offers a policy-oriented takeaway. This classic problem–evidence–analysis–conclusion structure suits the comparative research format well.
Introduction
"How can it be that the richest, most powerful nation on earth can tolerate 47 million uninsured, the highest health care costs per capita by far on earth, and health outcomes that put the United States well down in the ranking of developed countries?" — Daniel Callahan
As this epigraph indicates, Americans are spending more and receiving less in terms of the quality and accessibility of their health care compared to European nations that spend less — in some cases far less — per capita. Moreover, recent trends indicate that the disproportion between the U.S. and European nations continues to grow, suggesting that several persistent factors are driving these differences and continue to cost Americans more of their tax dollars. The purpose of this paper is to review the literature to identify these factors and explain their implications for the health care systems in the U.S. and Europe, including the reasons for the higher costs of health insurance in the U.S. A summary of the research and important findings is provided in the conclusion.
Works Cited
Allison, Bill. "Big Pharma Lobby Group Spent Record Amount as Reform Push Grows." Bloomberg, Jan. 2019, p. 1.
Callahan, Daniel. "Europe and the United States: Contrast and Convergence." Journal of Medicine & Philosophy, vol. 33, no. 3, June 2018, pp. 280–93.
Ginter, Emil, and Vladimir Simko. "Health Differences between Populations of the United States of America and the European Union." Central European Journal of Public Health, vol. 18, no. 4, Dec. 2010, pp. 215–18.
Glaser, W. A. "Paying the Hospital: American Problems and Foreign Solutions." International Journal of Health Services: Planning, Administration, Evaluation, vol. 21, no. 3, 1991, pp. 389–99.
Gray, Bradford H., and Ewout van Ginneken. "Health Care for Undocumented Migrants: European Approaches." Issue Brief (Commonwealth Fund), vol. 33, Dec. 2012, pp. 1–12.
"How Does the U.S. Health Care System Compare to Other Countries." Peter G. Peterson Foundation. 2022. Available: https://www.pgpf.org/blog/2022/07/how-does-the-us-healthcare-system-compare-to-other-countries.
Kanter, Jeremy B., Deadric T. Williams, and Amy J. Rauer. "Strengthening Lower-income Families: Lessons Learned from Policy Responses to the COVID-19 Pandemic." Family Process 60, no. 4 (December 2021): 1389–1402.
"Life Expectancy." World Data. 2023. Available: https://www.worlddata.info/life-expectancy.php.
McMichen, Grady. "The Coordinated Exploitation of the United States Government by the Healthcare Industry." Journal of Law & Health, vol. 36, no. 1, Dec. 2022, pp. 34–62.
"U.S. People." CIA World Factbook. 2023. Available: https://www.cia.gov/the-world-factbook/countries/united-states/#people-and-society.
Create your account
Always verify citation format against your institution’s current style guide requirements.